Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

Retatrutide, an experimental obesity drug from Eli Lilly, harnesses three hormones to control eating and could “someday” lead to similar levels of weight loss that are seen with bariatric surgery. stephanie gosk reports.

TODAY

3,955,278 subscribers

25,466 views • 3 years ago •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

2 Comments

TODAY3 years ago

Here's what to know about the new oral weight loss pills that could be on the market in the coming years.

Kevin Parrotte, Retired ASE Master Auto Technician3 years ago

@stephgosk Aren't we just keeping genetic defects around, subverting evolution?

Related Videos

Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting the drug for approval from the Food and Drug Administration. CBS News’ Jonathan LaPook, M.D explains.

Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting the drug for approval from the Food and Drug Administration. CBS News’ Jonathan LaPook, M.D explains.

CBS Evening News

20,162 views • 1 year ago

President Trump announced deals with drug companies Eli Lilly and Novo Nordisk to lower costs for many Americans of GLP-1 weight loss drugs on Thursday.

President Trump announced deals with drug companies Eli Lilly and Novo Nordisk to lower costs for many Americans of GLP-1 weight loss drugs on Thursday.

ABC News

18,011 views • 9 months ago

.President Donald J. Trump: "Today, Eli Lilly and Novo Nordisk are joining the phenomenal list of the most exciting announcements... these are two companies behind the groundbreaking weight loss drugs that have helped millions of Americans struggling with obesity."

.President Donald J. Trump: "Today, Eli Lilly and Novo Nordisk are joining the phenomenal list of the most exciting announcements... these are two companies behind the groundbreaking weight loss drugs that have helped millions of Americans struggling with obesity."

Rapid Response 47

62,652 views • 9 months ago

President Trump announces that two of the world's largest pharmaceutical manufacturers (Eli Lilly and Novartis) have agreed to offer their most popular GLP-1 weight loss drug (Ozempic) at drastic discounts.

President Trump announces that two of the world's largest pharmaceutical manufacturers (Eli Lilly and Novartis) have agreed to offer their most popular GLP-1 weight loss drug (Ozempic) at drastic discounts.

RSBN 🇺🇸

19,435 views • 9 months ago

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Drug Administration hasn't reviewed whether it is safe and effective, which is the legal path for prescription drugs to come to market. And yet retatrutide is for sale all over the internet, a phenomenon with no modern precedent. Adam Yamaguchi

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Drug Administration hasn't reviewed whether it is safe and effective, which is the legal path for prescription drugs to come to market. And yet retatrutide is for sale all over the internet, a phenomenon with no modern precedent. Adam Yamaguchi

CBS News

45,586 views • 2 months ago

JUST IN: President Trump announced a deal with drug companies Eli Lilly and Novo Nordisk to lower costs for many Americans on GLP-1 weight loss drugs on Thursday.

JUST IN: President Trump announced a deal with drug companies Eli Lilly and Novo Nordisk to lower costs for many Americans on GLP-1 weight loss drugs on Thursday.

ABC News

33,649 views • 9 months ago

🚨 BREAKING: President Trump announces that two of the world's largest pharmaceutical manufacturers (Eli Lilly and Novartis) Have agreed to offer their most popular GLP-1 weight loss drug (Ozempic) at drastic discounts.

🚨 BREAKING: President Trump announces that two of the world's largest pharmaceutical manufacturers (Eli Lilly and Novartis) Have agreed to offer their most popular GLP-1 weight loss drug (Ozempic) at drastic discounts.

Died Suddenly

53,815 views • 9 months ago

UK obesity rates could decline as soon as 2025 thanks to weight loss drugs. Sky's Thomas Moore reports from a weight loss drugs distribution hub where they have supplied 200,000 patients with Wegovy - a medicine growing in popularity.

UK obesity rates could decline as soon as 2025 thanks to weight loss drugs. Sky's Thomas Moore reports from a weight loss drugs distribution hub where they have supplied 200,000 patients with Wegovy - a medicine growing in popularity.

Sky News

41,359 views • 1 year ago

Glad to see ⁦U.S. FDA⁩ approve a pill version of this new class of weight loss drugs. Many can benefit with more affordable and convenient access. Remarkable work from ⁦Eli Lilly and Company

Glad to see ⁦U.S. FDA⁩ approve a pill version of this new class of weight loss drugs. Many can benefit with more affordable and convenient access. Remarkable work from ⁦Eli Lilly and Company

Dr. Vin Gupta

12,930 views • 4 months ago

Bariatric Surgery: Sleeve Gastrectomy is a minimally invasive procedure that removes upto 70% of the stomach, leading to significant weight loss, often resolving diabetes and hypertension. Far from being just cosmetic, it offers curative benefits for many metabolic conditions.

Bariatric Surgery: Sleeve Gastrectomy is a minimally invasive procedure that removes upto 70% of the stomach, leading to significant weight loss, often resolving diabetes and hypertension. Far from being just cosmetic, it offers curative benefits for many metabolic conditions.

Mbiine Ronald

20,153 views • 1 year ago

Retatrutide just posted Phase 3 numbers that are hard to ignore. ~30% average body weight loss. ~70 pounds lost. Even the lowest dose outperformed what used to be considered best-in-class. But the most interesting part of the story isn't the weight loss. It's the thousands of people already using grey-market Retatrutide before there's an approved pharmacy version available. What did the trials actually do? What dose produced the best balance of results and tolerability? And why might the biggest risk have nothing to do with the drug itself?

Retatrutide just posted Phase 3 numbers that are hard to ignore. ~30% average body weight loss. ~70 pounds lost. Even the lowest dose outperformed what used to be considered best-in-class. But the most interesting part of the story isn't the weight loss. It's the thousands of people already using grey-market Retatrutide before there's an approved pharmacy version available. What did the trials actually do? What dose produced the best balance of results and tolerability? And why might the biggest risk have nothing to do with the drug itself?

Dr. Alex Tatem

232,738 views • 2 months ago

The US Food and Drug Administration approved Novo Nordisk's weight-loss pill, giving the drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly

The US Food and Drug Administration approved Novo Nordisk's weight-loss pill, giving the drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly

Reuters

21,429 views • 8 months ago

“This is going to be a trillion-dollar drug.” Andrew D. Huberman, Ph.D. says retatrutide is the peptide that’s about to “change everything.” Currently in a Phase III clinical trial in humans, retatrutide caused up to one-third body weight loss in just six months, with some degree of muscle sparing. “The bodybuilding community has been onto this for a long time.” “Then it shows up in Hollywood. Everyone lies or avoids answering the question of how they got so jacked. They talk about eating chicken breasts, and they’re actually taking growth hormone, Winstrol, and retatrutide.” “We are looking at a potential change in the laws around peptides such that buying peptides would become illegal. I think this is a terrible idea, but the motivation behind this is largely because Eli Lilly owns the patent.” “Lilly would like to protect the domain over that patent. This is going to be a trillion-dollar drug.”

“This is going to be a trillion-dollar drug.” Andrew D. Huberman, Ph.D. says retatrutide is the peptide that’s about to “change everything.” Currently in a Phase III clinical trial in humans, retatrutide caused up to one-third body weight loss in just six months, with some degree of muscle sparing. “The bodybuilding community has been onto this for a long time.” “Then it shows up in Hollywood. Everyone lies or avoids answering the question of how they got so jacked. They talk about eating chicken breasts, and they’re actually taking growth hormone, Winstrol, and retatrutide.” “We are looking at a potential change in the laws around peptides such that buying peptides would become illegal. I think this is a terrible idea, but the motivation behind this is largely because Eli Lilly owns the patent.” “Lilly would like to protect the domain over that patent. This is going to be a trillion-dollar drug.”

TBPN

1,977,854 views • 6 months ago

Quadruple murder suspect Bryan Kohberger is expected back in an Idaho court Thursday as new details leading up to his arrest are revealed. stephanie gosk reports and NBC senior legal correspondent Laura Jarrett joins with analysis.

Quadruple murder suspect Bryan Kohberger is expected back in an Idaho court Thursday as new details leading up to his arrest are revealed. stephanie gosk reports and NBC senior legal correspondent Laura Jarrett joins with analysis.

TODAY

12,688 views • 3 years ago

Happening Now in the Oval Office with a behind the scenes view—President Trump: “Pharmaceutical companies Eli Lilly and Company and Novo Nordisk have agreed to offer their most popular GLP-1 weight loss drug, I call it the fat drug…at drastic discounts…” LIVE The White House X!

Happening Now in the Oval Office with a behind the scenes view—President Trump: “Pharmaceutical companies Eli Lilly and Company and Novo Nordisk have agreed to offer their most popular GLP-1 weight loss drug, I call it the fat drug…at drastic discounts…” LIVE The White House X!

Dan Scavino

241,611 views • 9 months ago

An ＠ITVNews investigation has found people with healthy BMIs are accessing weight-loss jabs from online pharmacies by using AI to edit their pictures to make themselves look bigger. Our reporter, Cree-Summer Haughton, submitted an altered image of herself to six different pharmacies and was sent weight-loss jabs by three of them without further checks.

An ＠ITVNews investigation has found people with healthy BMIs are accessing weight-loss jabs from online pharmacies by using AI to edit their pictures to make themselves look bigger. Our reporter, Cree-Summer Haughton, submitted an altered image of herself to six different pharmacies and was sent weight-loss jabs by three of them without further checks.

Good Morning Britain

22,639 views • 7 months ago

A brand new drug from $BHVN promises to promote muscle gain in patients taking GLP-1 obesity drugs CEO Vlad Coric breaks down the treatment's latest clinical trial results and how soon it could impact patients and the weight loss space:

CNBC's Fast Money

39,012 views • 2 years ago